DDX39 acts as a suppressor of invasion for bladder cancer

作者：Kato Minoru; Wei Min; Yamano Shotaro; Kakehashi Anna; Tamada Satoshi; Nakatani Tatsuya; Wanibuchi Hideki^*

来源：Cancer Science, 2012, 103(7): 1363-1369.

DOI：10.1111/j.1349-7006.2012.02298.x

The object of the present study was to identify markers for predicting urinary bladder cancer progression by comparative proteome analysis of bladder cancers and paired normal mucosas. We found that DDX39 was overexpressed in four of six bladder cancers examined compared with respective control tissues. Immunohistochemical analysis using 303 bladder cancer specimens revealed that DDX39 was inversely correlated to pT stage and histological grade progression. The incidence of DDX39high tumors (positive cells =50%) was 68.6%, 43.5%, 20.0%, and 5.3% in pTa, pT1, pTis, and =pT2 tumors, respectively, and 65.2%, 60.7%, and 19.6% in G1, G2, and G3 tumors, respectively. The incidence of DDX39high tumors was significantly lower in pT1 and =pT2 compared to pTa tumors, and also significantly lower in G3 compared to G1 and G2 tumors. Follow-up analysis (n = 105) revealed that DDX39low tumors (positive cells %26lt;50%) were associated with disease progression (hazard ratio 7.485; P = 0.0083). Furthermore, DDX39-knockdown bladder cancer cells increased their invasion ability compared to negative control cells. These results suggest that DDX39 is a suppressor of invasion and loss of its function predicts disease progression in bladder cancers. (Cancer Sci 2012; 103: 13631369)

• 出版日期2012-7